<DOC>
	<DOCNO>NCT02456532</DOCNO>
	<brief_summary>This proposal assess risk transition therapeutic hypnotic use abuse people insomnia . The investigator study hypothesize at-risk sub-population , insomniac hyperarousal , compare two hypnotic , drug mood effect , eszopiclone , versus one without mood effect , zolpidem .</brief_summary>
	<brief_title>Safety Efficacy Chronic Hypnotic Use 2</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Eszopiclone</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<mesh_term>Hypnotics Sedatives</mesh_term>
	<criteria>DSM5 diagnosis insomnia acute unstable medical disease , current past history psychiatric disease , alcoholism drug abuse , primary sleep disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>